{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:05:21Z","timestamp":1790345121626,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008741","name":"EULAR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ero.2026.100211","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T19:54:00Z","timestamp":1786391640000},"page":"100211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic literature review informing the 2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis: focus on referral and diagnosis"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8242-6798","authenticated-orcid":false,"given":"Alice","family":"Bartoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinalini","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga Prasanna","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Ducker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Losasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Studenic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan B","family":"Mukhtyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-3726","authenticated-orcid":false,"given":"Elena","family":"Nikiphorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2026.100211_bib0001","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ero.2026.100211_bib0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ero.2026.100211_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001003","article-title":"Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis","volume":"5","author":"Monti","year":"2019","journal-title":"RMD Open."},{"key":"10.1016\/j.ero.2026.100211_bib0004","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard-2023-224543","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","volume":"83","author":"Dejaco","year":"2024","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ero.2026.100211_bib0005","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100211_bib0006","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.ero.2026.100211_bib0007","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11926-020-00948-x","article-title":"Pathogenesis of giant cell arteritis and Takayasu arteritis\u2014similarities and differences","volume":"22","author":"Watanabe","year":"2020","journal-title":"Curr Rheumatol Rep."},{"key":"10.1016\/j.ero.2026.100211_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ero.2026.100211_bib0009","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/annrheumdis-2021-221126","article-title":"Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2\/3 randomised controlled trial","volume":"81","author":"Bonelli","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ero.2026.100211_bib0010","unstructured":"A systematic review to inform the updated EULAR guidelines on the diagnosis and management of patients with suspected giant cell arteritis, polymyalgia rheumatica, large vessel vasculitis and Takayasu arteritis 2024. https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024560403. accessed June 1, 2024."},{"key":"10.1016\/j.ero.2026.100211_bib0011","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev."},{"key":"10.1016\/j.ero.2026.100211_bib0012","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"10.1016\/j.ero.2026.100211_bib0013","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp; 2019. accessed June 1, 2024."},{"key":"10.1016\/j.ero.2026.100211_bib0014","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/rheumatology\/keae531","article-title":"Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic","volume":"64","author":"Cowley","year":"2025","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100211_bib0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41927-021-00210-6","article-title":"The fast-track outpatient clinic significantly decreases hospitalisation rates among polymyalgia rheumatica patients","volume":"5","author":"Chrysidis","year":"2021","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.ero.2026.100211_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105185","article-title":"Fast track clinic for early diagnosis of polymyalgia rheumatica: impact on symptom duration and prednisolone initiation","volume":"88","author":"Fr\u00f8lund","year":"2021","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.ero.2026.100211_bib0017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/kead189","article-title":"Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica","volume":"63","author":"De Miguel","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.100211_bib0018","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221149963","article-title":"Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica \u2013 a prospective cohort study","volume":"15","author":"Burg","year":"2023","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"10.1016\/j.ero.2026.100211_bib0019","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/rheumatology\/keae463","article-title":"Low incidence of late-onset giant cell arteritis during the first year in patients with polymyalgia rheumatica\u2013a repeated imaging study","volume":"64","author":"Nielsen","year":"2025","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100211_bib0020","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1093\/rheumatology\/keae208","article-title":"Prevalence, characteristics, and outcome of subclinical vasculitis in polymyalgia rheumatica: a retrospective cohort study","volume":"63","author":"Moreel","year":"2024","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100211_bib0021","first-page":"A5410","article-title":"PET-CT findings in patients with polymyalgia rheumatica without symptoms of cranial ischaemia","volume":"64","author":"Lund-Petersen","year":"2017","journal-title":"Dan Med J."},{"key":"10.1016\/j.ero.2026.100211_bib0022","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.reuma.2018.02.009","article-title":"18 F-FDG PET\/TC en pacientes con polimialgia reum\u00e1tica: despistando vasculitis","volume":"16","author":"Ar\u00e9valo Ruales","year":"2020","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.ero.2026.100211_bib0023","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejim.2024.01.022","article-title":"The usefulness of 18F-FDG-PET\/CT in detecting musculoskeletal and vascular involvement in patients with polymyalgia rheumatica receiving glucocorticoids","volume":"124","author":"Serrano-Combarro","year":"2024","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.ero.2026.100211_bib0024","first-page":"275","article-title":"18F-FDG PET\/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica","volume":"34","author":"Lavado-P\u00e9rez","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"10.1016\/j.ero.2026.100211_bib0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard-2023-224768","article-title":"Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica","volume":"83","author":"De Miguel","year":"2024","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ero.2026.100211_bib0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10067-023-06739-w","article-title":"Diagnostic delay in patients with giant cell arteritis: results of a fast-track clinic","volume":"43","author":"van Nieuwland","year":"2024","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.ero.2026.100211_bib0027","doi-asserted-by":"crossref","first-page":"206","DOI":"10.7861\/clinmed.2022-0415","article-title":"Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis","volume":"23","author":"Smith","year":"2023","journal-title":"Clin Med (Lond)."},{"key":"10.1016\/j.ero.2026.100211_bib0028","article-title":"Fast-track ultrasound clinic for the diagnosis of giant cell arteritis changes the prognosis of the disease but not the risk of future relapse","volume":"7","author":"Monti","year":"2020","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.ero.2026.100211_bib0029","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/M23-3417","article-title":"Diagnostic strategy using color Doppler ultrasound of temporal Arteries in patients with high clinical suspicion of giant cell arteritis: a prospective cohort study","volume":"177","author":"Denis","year":"2024","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.ero.2026.100211_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.medcli.2023.11.021","article-title":"Utilidad de la aplicaci\u00f3n de un algoritmo diagn\u00f3stico en la arteritis de c\u00e9lulas gigantes en funci\u00f3n del grado de sospecha cl\u00ednica","volume":"163","author":"Estrada","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ero.2026.100211_bib0031","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/rheumatology\/keae493","article-title":"Ultrasonography-led multimodal diagnostic pathway for giant cell arteritis","volume":"64","author":"Mukhtyar","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.100211_bib0032","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MNM.0000000000001670","article-title":"Fast-track pathway for early diagnosis and management of giant cell arteritis: the combined role of vascular ultrasonography and [18F]-fluorodeoxyglucose PET-computed tomography imaging","volume":"44","author":"Ludwig","year":"2023","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.ero.2026.100211_bib0033","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41433-022-02132-0","article-title":"Role of Temporal artery biopsy in a sequential Giant Cell Arteritis fast-track pathway: a 5-year prospective study","volume":"37","author":"Sachdev","year":"2023","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.ero.2026.100211_bib0034","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jvs.2022.04.043","article-title":"The utility of the bilateral temporal artery biopsy for diagnosis of giant cell arteritis","volume":"76","author":"Mehta","year":"2022","journal-title":"J Vasc Surg."},{"key":"10.1016\/j.ero.2026.100211_bib0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WNO.0000000000001535","article-title":"Effect of temporal artery biopsy length and laterality on diagnostic yield","volume":"42","author":"Shen","year":"2022","journal-title":"J Neuroophthalmol."},{"key":"10.1016\/j.ero.2026.100211_bib0036","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamaophthalmol.2020.6896","article-title":"Discordance rate among bilateral simultaneous and sequential temporal artery biopsies in giant cell arteritis: role of frozen sectioning based on the Mayo Clinic experience","volume":"139","author":"Cohen","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ero.2026.100211_bib0037","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jss.2020.12.036","article-title":"Evaluation of temporal artery duplex ultrasound for diagnosis of temporal arteritis","volume":"261","author":"Gielis","year":"2021","journal-title":"J Surg Res."},{"key":"10.1016\/j.ero.2026.100211_bib0038","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/RHU.0000000000001938","article-title":"The effect of corticosteroids on temporal artery biopsy positivity in giant cell arteritis: timing is everything","volume":"29","author":"Papadakos","year":"2023","journal-title":"J Clin Rheumatol."},{"key":"10.1016\/j.ero.2026.100211_bib0039","article-title":"PET\/CT compared with temporal artery biopsy for giant cell arteritis","volume":"70","author":"Lamb\u00e6k","year":"2023","journal-title":"Dan Med J."},{"key":"10.1016\/j.ero.2026.100211_bib0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/1756-185X.14288","article-title":"The diagnostic accuracy of temporal artery ultrasound and temporal artery biopsy in giant cell arteritis: a single center Australian experience over 10 years","volume":"25","author":"He","year":"2022","journal-title":"Int J Rheum Dis."},{"key":"10.1016\/j.ero.2026.100211_bib0041","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/acr2.11346","article-title":"Vascular ultrasound for giant cell arteritis: establishing a protocol using vascular sonographers in a fast-track clinic in the United States","volume":"4","author":"Oshinsky","year":"2022","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.ero.2026.100211_bib0042","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/acr2.11628","article-title":"Determination of the value of color Doppler ultrasound in patients with a clinical suspicion of giant cell arteritis","volume":"6","author":"Kaandorp","year":"2024","journal-title":"ACR Open Rheumatol."},{"key":"10.1016\/j.ero.2026.100211_bib0043","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1093\/rheumatology\/keae551","article-title":"Serial assessment of ultrasound sensitivity and scores in patients with giant cell arteritis before and 3 and 10 days after treatment","volume":"64","author":"Hansen","year":"2025","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100211_bib0044","doi-asserted-by":"crossref","first-page":"rkab083","DOI":"10.1093\/rap\/rkab083","article-title":"Colour Doppler ultrasound and the giant cell arteritis probability score for the diagnosis of giant cell arteritis: a Canadian single-centre experience","volume":"5","author":"Zarka","year":"2021","journal-title":"Rheumatol Adv Pract."},{"key":"10.1016\/j.ero.2026.100211_bib0045","doi-asserted-by":"crossref","DOI":"10.1093\/intqhc\/mzae103","article-title":"Diagnostic performance of a newly launched Canadian fast-track ultrasound clinic by rheumatologists for the diagnosis of giant cell arteritis","volume":"36","author":"Mourot","year":"2024","journal-title":"Int J Qual Health Care."},{"key":"10.1016\/j.ero.2026.100211_bib0046","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.reuma.2018.08.007","article-title":"Estudio comparativo de la ecograf\u00eda Doppler frente a la biopsia de arteria temporal en el diagn\u00f3stico de la arteritis de c\u00e9lulas gigantes","volume":"16","author":"Gonz\u00e1lez Porto","year":"2020","journal-title":"Reumatol Clin (Engl Ed)."},{"key":"10.1016\/j.ero.2026.100211_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.011","article-title":"Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis","volume":"103","author":"de Boysson","year":"2019","journal-title":"J Autoimmun."},{"key":"10.1016\/j.ero.2026.100211_bib0048","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.autrev.2019.05.008","article-title":"Large-vessel vasculitis diagnosed between 50 and 60 years: case-control study based on 183 cases and 183 controls aged over 60 years","volume":"18","author":"Delaval","year":"2019","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.ero.2026.100211_bib0049","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.002080","article-title":"Novel biomarkers for the precisive diagnosis and activity classification of Takayasu arteritis","volume":"12","author":"Cui","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.ero.2026.100211_bib0050","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol."}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126001102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126001102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:31:48Z","timestamp":1790343108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708126001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3050708126001102"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2026.100211","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic literature review informing the 2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis: focus on referral and diagnosis","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2026.100211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100211"}}